Drugs
PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials.
Ibadete Bytyçi, Michael Y Henein, Sefer Bytyqi, Mentor Shatri, Drilon Gashi, Endrit Dragusha, Rozafa Koliqi, Shpend Elezi, Adrian V Hernandez, Maciej Banach
Published: 202610.1007/s40265-025-02272-z
Abstract
OBJECTIVE: The aim of this meta-analysis was to compare the efficacy of PCSK9 and ANGPTL3 inhibitors in patients with homozygous familial hypercholesterolemia (HoFH). METHODS: We systematically searched selected electronic databases until 30 November…
Preview only. Read the full abstract at the source